AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV - Changing to HIV.gov in Spring 2017

MENU

NIAID

Spotlight on: #HeartHealth and People Living with HIV

February is heart health month, a perfect time to focus our attention on an important area of concern in the HIV community: cardiovascular health. People living with HIV who are on treatment and maintain viral suppression can expect to live a near-normal lifespan. However, even while taking antiretroviral therapy (ART), people living with HIV are up…

Final HIV Research Highlights from CROI 2017

As the 2017 Conference on Retroviruses and Opportunistic Infections  (CROI) wrapped up in Seattle, we spoke again with Dr. Carl Dieffenbach about some of the scientific highlights from the final day of the conference. Carl is the Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). He and…

More HIV Research Highlights from CROI 2017

New scientific findings from two separate domains were among the key highlights shared during the second day of the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, according to Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). Dr. Dieffenbach and his colleague Anne…

Highlights from First Day of CROI 2017

This week, we’re at the 2017 Conference on Retroviruses and Opportunistic Infections   (CROI) in Seattle sharing news and information about some of the important new HIV research findings and data being released. After the first full day of sessions, we held two Facebook Live sessions with senior federal HIV leaders to hear about what they saw…

This February, Take Heart: NIH is Committed to Preventing HIV-Related Heart Attacks and Strokes

Antiretroviral therapy (ART) has transformed HIV infection from an almost-always fatal disease to what is now a manageable, chronic health condition. Today, a person diagnosed with HIV at age 20 can expect to live a nearly normal lifespan, or until about age 71—39 years more, on average, than a person with HIV diagnosed at the…

Facebook Live From CROI: This Week’s Schedule

As Dr. Richard Wolitski, Director of the Office of HIV/AIDS and Infectious Disease Policy, shared in a post last week, AIDS.gov will be sharing via Facebook Live interviews with senior HHS HIV leaders and highlights of the science being discussed this week at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle. Below is…

Prevention Studies In 2016 Set the Stage for Progress

It is fitting that in the year that we marked the 35th anniversary of the first recognition of what would come to be known as HIV, we’ve taken major steps toward revolutionizing how we could prevent this disease. In 2016 we began four important clinical studies that promise to inform HIV prevention research, which may…

Historic HIV Vaccine Clinical Trial: Facebook Live with NIH’s Dr. Dieffenbach

In a Facebook Live interview from Cape Town, South Africa earlier this week, we heard from NIH’s Dr. Carl Dieffenbach about the exciting launch of HVTN 702, a new HIV vaccine clinical trial supported by NIH. The first HIV vaccine efficacy study to launch anywhere in seven years, HVTN 702 is testing whether an experimental…